
zzso patients zzso male, 50 zzso age zzso 56 years; range, zzso zzso with solid tumors (21 breast zzso 6 zzso 2 zzso zzso 1 pancreatic zzso 1 zzso and 1 lung zzso and zzso zzso (24 multiple zzso 32 zzso and 10 zzso zzso were recruited into the zzso The patients received at least three cycles of chemotherapy with zzso zzso zzso zzso and zzso zzso with or without zzso A total of 325 cycles of chemotherapy were zzso The symptoms were evaluated by means of a score system on the basis of which zzso sensation of zzso zzso and zzso were assessed by zzso and degree of zzso Before initiation of zzso therapy with zzso 47 patients zzso had symptoms during chemotherapy zzso sensation of zzso zzso zzso After initiation of therapy with zzso these symptoms improved in 42 patients zzso in 6 patients there was a zzso increase in heartburn and zzso All other patients remained without symptoms in spite of zzso The evaluation of the patient population as a whole showed a significant decrease of zzso heartburn zzso less than zzso and zzso zzso less than zzso during zzso zzso This was tolerated extremely well; side effects were not zzso To zzso this prospective clinical study shows that zzso is an effective and suitable therapeutic principle in long-term therapy for the treatment and prophylaxis of zzso gastrointestinal zzso 

